Vienna, Austria: 26th Annual EAU Congress tackles controversial issues in urology
Wednesday, 9 March 2011- Some of the most pressing issues in urology will be addressed next week during the 26th Annual EAU Congress in Vienna, Austria, from March 18 to 22. Four plenary sessions, which will open each of the congress days, will examine issues in uro-oncology, andrology, paediatric and reconstructive urology, stones, functional urology, to name a few.
"Every plenary session follows a particular theme and this has proven to be very successful as people can spend extended periods of time on topics that interest them," said Prof. Freddie Hamdy, UK, Chairman of the EAU Scientific Congress Office. "The scientific programme is very well thought-through and carefully prepared."
A special plenary session will also be organised at the occasion of the traditional full-day event – Urology Beyond Europe, with 10 international and regional urological associations participating, including the Pan-African Urological Surgeon’s Association (PAUSA) which is officially attending the annual EAU congress for the first time.
Saturday, March 19, marks the start of the first plenary session with Professors Walter Artibani (Italy) and Francisco Cruz (Portugal) as chairmen. The session will explore new insights on the overactive bladder and features two case discussions and two state-of-the-art lectures. Also during this session, guest speaker Prof. G. Badlani from the AUA will be making a case for the role of genes in OAB.
On Sunday, Professors Freddie Hamdy and Manfred Wirth will co-chair the plenary session on high-risk prostate cancer. Wirth will first introduce the topic, and then moderate a debate on the risk classification of the disease.
"High-risk PCa is a controversial subject and there is still much uncertainty about how to best recognise, treat and monitor it," said Hamdy. "We have tried to pull together a session which would cover all these aspects. High-risk cancer costs lives and we have focused this session in such a way as to discuss a wide range of factors that help us to diagnose our patients more accurately, as well as ratify, monitor and improve their treatment outcome."
The rest of the morning is taken up with two pairs of case discussions and state-of-the-art lectures. The discussions are moderated panel sessions with many participants from different parts of the world. They cover optimal treatment of high-risk PCa and metastasis of the disease. Both state-of-the-art lectures cover new developments in treatment, one focusing on androgen suppression and the other – on chemotherapy, vaccines and small molecules.
The third plenary session, taking place on Monday, covers trauma and reconstruction. It is co-chaired by Professors Chris Chapple (UK) and Luis Martínez-Piñeiro (Spain).
"This session will update the attendee on the appropriate management of traumatic urethral rupture and of urethral stricture," said Chapple. The sessions will also feature a lecture by Prof. Dr. Margit Fisch (Germany) on surgery required by complications after radical prostatectomy. The EAU Guidelines Office will be presenting its report on single port laparoscopy and robotic surgery, and the Novel Therapy Highlights section will offer attendees the results of two new studies.
The fourth session is on organ-preserving treatment of urological cancers. Chaired by Professors Cesare Selli (Italy) and Bertrand Tombal (Belgium) it features several lectures and presentations that are unique to this final plenary session.
By Loek Keizer